午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Guangzhou Weiaokang Pharmaceutical Technology Co., Ltd

Firmenname:Guangzhou Weiaokang Pharmaceutical Technology Co., Ltd
Telefon:-+86-13424074264
E-Mail:pengguizi@cti-cert.com
Nationalit?t:China
URL:
Produkte insgesamt:100
1

Produktkatalog

Dexpanthenol Impurity3C10H19NO5
ETHYL 4-METHOXYBENZOYLACETATE; PhEur/USP(DMF)Ethyl-p-anisoylacetat2881-83-6C12H14O4
Olaparib; PhEur/USP(DMF)763113-22-0C24H23FN4O3
Ruxolitinib; PhEur/USP(DMF)941678-49-5C17H18N6
Trametinib Impurity 13871700-32-2C25H21FIN3O6S
Osimertinib; PhEur/USP(DMF)1421373-65-0C28H33N7O2
Baricitinib? Impurity 4
Baricitinib? Impurity 7
Trametinib Impurity 20871701-23-4C26H23FIN5O4
Trametinib Impurity 17871700-65-1C26H24FN5O4
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one; PhEur/USP(DMF)1,2,4-Triazolo[4,3-a]pyridin-3(2H)-on6969-71-7C6H5N3O
Crizotinib; PhEur/USP(DMF)877399-52-5C21H22Cl2FN5O
Trametinib Impurity 11871700-25-3C26H23FIN5O4
Avibactam INT 1; PhEur/USP(DMF)1416134-48-9C17H24N2O7
1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride; PhEur/USP(DMF)1-(3-Chlorphenyl)-4-(3-chlorpropyl)piperaziniumchlorid52605-52-4C13H19Cl3N2
Baricitinib? Impurity 1C15H15N7O2S
Trametinib Impurity 16C26H23FIN5O5
Trametinib Impurity 193018911-27-5C17H17FIN3O3
Atrasentan? Impurity 24
Trametinib Impurity 06
Sunitinib Malate; PhEur/USP(DMF)341031-54-7C26H33FN4O7
Erlotinib hydrochloride; PhEur/USP(DMF)183319-69-9C22H24ClN3O4
Trametinib Impurity 21871701-87-0C24H21FIN5O3
Methylene Blue; PhEur/USP(DMF)Methylenblau (C.I. 52015)61-73-4C16H18ClN3S
2-(3-bromo-4,5-dimethoxyphenyl)ethan-1-amine hydrochloride; PhEur/USP(DMF)92015-18-4C10H14BrNO2.ClH
Ethyl 4-(ethoxycarbonyl)piperidine-1-acetate; PhEur/USP(DMF)Ethyl-4-(ethoxycarbonyl)piperidin-1-acetat1838-39-7C12H21NO4
Atrasentan? Impurity 18
Pomalidomide; PhEur/USP(DMF)19171-19-8C13H11N3O4
Trazodone hydrochloride; PhEur/USP(DMF)2-[3-[4-(3-Chlorphenyl)piperazin-1-y]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-onhydrochlorid25332-39-2C19H23Cl2N5O
5-BROMOVERATRALDEHYDE; PhEur/USP(DMF)3-Brom-4,5-dimethoxybenzaldehyd6948-30-7C9H9BrO3
Baricitinib? Impurity 5
Methylene Blue trihydrate; PhEur/USP(DMF)7220-79-3C16H20ClN3OS
Dexpanthenol Impurity1α-Hydroxy-β,β-dimethyl-γ-butyrolactonC6H10O3
LenalidoMide; PhEur/USP(DMF)191732-72-6C13H13N3O3
4-chloro-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine; PhEur/USP(DMF)941685-26-3C12H18ClN3OSi
Trametinib Impurity 02871700-28-6C13H11FIN3O2
Trametinib Impurity 12871700-24-2C18H15FIN3O4
lenvatinib Mesylate; PhEur/USP(DMF)857890-39-2C22H23ClN4O7S
tert-butyl 4-((1R,2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate; PhEur/USP(DMF)1174020-63-3C24H34N4O5
1,3-Benzodioxole,5-[(1E)-2-nitroethenyl]-; PhEur/USP(DMF)22568-48-5C9H7NO4
Baricitinib? Impurity 2
Dasatinib; PhEur/USP(DMF)302962-49-8C22H26ClN7O2S
Trametinib Impurity 03871700-30-0C16H16FIN4O2
(2S,3S,4R)-ethyl 4-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate; PhEur/USP(DMF)173937-93-4C21H23NO5
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile; PhEur/USP(DMF)1187594-13-3C22H31N7O3SSi
Aceclidine hydrochloride; PhEur/USP(DMF)Chinuclidin-3-ylacetathydrochlorid6109-70-2C9H16ClNO2
3-Quinuclidinone hydrochloride; PhEur/USP(DMF)Chinuclidin-3-onhydrochlorid1193-65-3C7H12ClNO
3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-, (2R,3R,4S)-, (αS)-α-hydroxybenzeneacetate (9CI); PhEur/USP(DMF)195529-63-6C27H27NO8
(R)-(+)-Verapamilic Acid; PhEur/USP(DMF)38175-99-4C16H21NO4
Alectinib; PhEur/USP(DMF)1256580-46-7C30H34N4O2
2-[1-(ethylsulfonyl)azetidin-3-ylidene]acetonitrile; PhEur/USP(DMF)1187595-85-2C7H10N2O2S
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate; PhEur/USP(DMF)1174020-64-4C17H28N4O5
Methylene blue ; PhEur/USP(DMF)122965-43-9C16H20ClN3OS
Imatinib mesylate; PhEur/USP(DMF)220127-57-1C30H35N7O4S
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole; PhEur/USP(DMF)1029716-44-6C13H23BN2O3
tert-butyl 4-((2S,5R)-5-(benzyloxyamino)piperidine-2-carboxamido)piperidine-1-carboxylate 4-methylbenzenesulfonate; PhEur/USP(DMF)1510832-19-5C23H36N4O4
Trans-5-(Benzyloxyamino)piperidine-2-carboxylic acid; PhEur/USP(DMF)1501980-29-5C13H18N2O3
Baricitinib? Impurity 3
Baricitinib? Impurity 6C12H19N3O2Si
Papaverine hydrochloride; PhEur/USP(DMF)1-((3,4-Dimethoxyphenyl)methyl)-6,7-dimethoxyiso-chinolin-hydrochlorid61-25-6C20H22ClNO4
N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)acetamide; PhEur/USP(DMF)N-(3,4-Dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)acetamid139-76-4C20H25NO5
Trametinib Impurity 14
Atrasentan hydrochloride; PhEur/USP(DMF)195733-43-8C29H38N2O6.HCl
Dexpanthenol Impurity2C{6}H{11}NaO{4}
Ceritinib (LDK378); PhEur/USP(DMF)1032900-25-6C28H36ClN5O3S
N,N-dibutyl-2-chloro-Acetamide; PhEur/USP(DMF)2567-59-1C10H20ClNO
3-(2-Aminoethyl)benzoic acid methyl ester HCl; PhEur/USP(DMF)167846-36-8C10H14ClNO2
1-(3,4-dimethoxybenzyl)-3,4-dihydro-6,7-dimethoxyisoquinolinium chloride; PhEur/USP(DMF)1-(3,4-Dimethoxybenzyl)-3,4-dihydro-6,7-dimethoxyisochinoliniumchlorid5884-22-0C20H24ClNO4
atrasentan; PhEur/USP(DMF)173937-91-2C29H38N2O6
Sorafenib tosylate; PhEur/USP(DMF)475207-59-1C21H16ClF3N4O3.C7H8O3S
Tofacitinib citrate; PhEur/USP(DMF)540737-29-9C16H20N6O.C6H8O7
GSK1120212 (DMSO solvate); PhEur/USP(DMF)1187431-43-1C28H29FIN5O5S
ethyl 3-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxybenzoyl)-4-nitrobutanoate; PhEur/USP(DMF)173864-45-4C21H21NO8
Nilotinib Hydrochloride; PhEur/USP(DMF)923288-95-3C28H23ClF3N7O
methyl (2R,3R,4S)-4-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate; PhEur/USP(DMF)250583-09-6C20H21NO5
Quisinostat Impurity8
Trametinib Impurity 01
Atrasentan? Impurity 22
Atrasentan? Impurity 25
(S)-(-)-Verapamilic Acid; PhEur/USP(DMF)36622-24-9C16H21NO4
Atrasentan? Impurity 23
Atrasentan? Impurity 28
Atrasentan? Impurity 20
Trametinib Impurity 04
Trametinib Impurity 08
Atrasentan? Impurity 26
Trametinib Impurity 07
Atrasentan? Impurity 21
Trametinib Impurity 18
Quisinostat Impurity5
Quisinostat Impurity7
Quisinostat Impurity1
Quisinostat Impurity4
Atrasentan? Impurity 27
Trametinib Impurity 15329941-39-1C15H16N2O3S
Quisinostat Impurity6
Trametinib Impurity 10
Quisinostat Impurity2
Atrasentan? Impurity 19
Quisinostat Impurity3
1
Copyright 2019 ? ChemicalBook. All rights reserved